124 related articles for article (PubMed ID: 8806095)
41. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway.
Mo D; Fang H; Niu K; Liu J; Wu M; Li S; Zhu T; Aleskandarany MA; Arora A; Lobo DN; Madhusudan S; Balajee AS; Chi Z; Zhao Y
Cancer Res; 2016 May; 76(10):3057-66. PubMed ID: 27013200
[TBL] [Abstract][Full Text] [Related]
42. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
Villari D; Caruso R; Grosso M; Vitarelli E; Righi M; Barresi G
Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
[TBL] [Abstract][Full Text] [Related]
43. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences.
Chiaravalli AM; Furlan D; Facco C; Tibiletti MG; Dionigi A; Casati B; Albarello L; Riva C; Capella C
Virchows Arch; 2001 Jan; 438(1):39-48. PubMed ID: 11213834
[TBL] [Abstract][Full Text] [Related]
45. The association of urocortin expression with clinicopathologic parameters of gastric adenocarcinomas.
Cheng MF; Tsai WC; Yu-Chieh L; Hsia KT; Jin JS
Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):288-94. PubMed ID: 23531852
[TBL] [Abstract][Full Text] [Related]
46. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
47. Expression of interleukin 6 and its receptor in human gastric and colorectal cancers.
Matsuo K; Oka M; Murase K; Soda H; Isomoto H; Takeshima F; Mizuta Y; Murata I; Kohno S
J Int Med Res; 2003; 31(2):69-75. PubMed ID: 12760309
[TBL] [Abstract][Full Text] [Related]
48. Defining the invasive phenotype of proximal gastric cancer cells.
Schwartz GK; Wang H; Lampen N; Altorki N; Kelsen D; Albino AP
Cancer; 1994 Jan; 73(1):22-7. PubMed ID: 8275429
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly.
Arai T; Takubo K
Pathol Int; 2007 Jun; 57(6):303-14. PubMed ID: 17539960
[TBL] [Abstract][Full Text] [Related]
50. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
51. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer.
Picco G; Petti C; Sassi F; Grillone K; Migliardi G; Rossi T; Isella C; Di Nicolantonio F; Sarotto I; Sapino A; Bardelli A; Trusolino L; Bertotti A; Medico E
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27771609
[TBL] [Abstract][Full Text] [Related]
53. Non-random primary and secondary chromosomal abnormalities in human gastric cancers.
Yadav M; Hopwood VL; Multani AS; Mansfield PF; Takahashi Y; McIntyre BW; Udagawa T; Pathak S
Anticancer Res; 1996; 16(4A):1787-95. PubMed ID: 8712702
[TBL] [Abstract][Full Text] [Related]
54. Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability.
Kim MS; Lee SH; Yoo NJ; Lee SH
Hum Pathol; 2013 Oct; 44(10):2064-70. PubMed ID: 23759652
[TBL] [Abstract][Full Text] [Related]
55. Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.
Mimori K; Inoue H; Alder H; Ueo H; Tanaka Y; Mori M
Oncol Rep; 2001; 8(1):39-42. PubMed ID: 11115566
[TBL] [Abstract][Full Text] [Related]
56. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
Ross DD; Yang W; Abruzzo LV; Dalton WS; Schneider E; Lage H; Dietel M; Greenberger L; Cole SP; Doyle LA
J Natl Cancer Inst; 1999 Mar; 91(5):429-33. PubMed ID: 10070941
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of differentiation status in gastric cancer.
Feng F; Liu J; Wang F; Zheng G; Wang Q; Liu S; Xu G; Guo M; Lian X; Zhang H
BMC Cancer; 2018 Sep; 18(1):865. PubMed ID: 30176846
[TBL] [Abstract][Full Text] [Related]
58. Expression of the E2F family in human gastrointestinal carcinomas.
Suzuki T; Yasui W; Yokozaki H; Naka K; Ishikawa T; Tahara E
Int J Cancer; 1999 May; 81(4):535-8. PubMed ID: 10225440
[TBL] [Abstract][Full Text] [Related]
59. Genetic alterations in the human Tcf-4 gene in Japanese patients with sporadic gastrointestinal cancers with microsatellite instability.
Saeki H; Tanaka S; Tokunaga E; Kawaguchi H; Ikeda Y; Maehara Y; Sugimachi K
Oncology; 2001; 61(2):156-61. PubMed ID: 11528255
[TBL] [Abstract][Full Text] [Related]
60. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Br J Cancer; 1995 Nov; 72(5):1200-10. PubMed ID: 7577468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
